Skip to main content
Top
Published in: Diabetologia 7/2018

Open Access 01-07-2018 | Article

Community-based pre-pregnancy care programme improves pregnancy preparation in women with pregestational diabetes

Authors: Jennifer M. Yamamoto, Deborah J. F. Hughes, Mark L. Evans, Vithian Karunakaran, John D. A. Clark, Nicholas J. Morrish, Gerry A. Rayman, Peter H. Winocour, Clare Hambling, Amanda W. Harries, Michael J. Sampson, Helen R. Murphy

Published in: Diabetologia | Issue 7/2018

Login to get access

Abstract

Aims/hypothesis

Women with diabetes remain at increased risk of adverse pregnancy outcomes associated with poor pregnancy preparation. However, women with type 2 diabetes are less aware of and less likely to access pre-pregnancy care (PPC) compared with women with type 1 diabetes. We developed and evaluated a community-based PPC programme with the aim of improving pregnancy preparation in all women with pregestational diabetes.

Methods

This was a prospective cohort study comparing pregnancy preparation measures before and during/after the PPC intervention in women with pre-existing diabetes from 1 June 2013 to 28 February 2017. The setting was 422 primary care practices and ten National Health Service specialist antenatal diabetes clinics. A multifaceted approach was taken to engage women with diabetes and community healthcare teams. This included identifying and sending PPC information leaflets to all eligible women, electronic preconception care templates, online education modules and resources, and regional meetings and educational events. Key outcomes were preconception folic acid supplementation, maternal HbA1c level, use of potentially harmful medications at conception and gestational age at first presentation, before and during/after the PPC programme.

Results

A total of 306 (73%) primary care practices actively participated in the PPC programme. Primary care databases were used to identify 5075 women with diabetes aged 18–45 years. PPC leaflets were provided to 4558 (89.8%) eligible women. There were 842 consecutive pregnancies in women with diabetes: 502 before and 340 during/after the PPC intervention. During/after the PPC intervention, pregnant women with type 2 diabetes were more likely to achieve target HbA1c levels ≤48 mmol/mol (6.5%) (44.4% of women before vs 58.5% of women during/after PPC intervention; p = 0.016) and to take 5 mg folic acid daily (23.5% and 41.8%; p = 0.001). There was an almost threefold improvement in ‘optimal’ pregnancy preparation in women with type 2 diabetes (5.8% and 15.1%; p = 0.021). Women with type 1 diabetes presented for earlier antenatal care during/after PPC (54.0% vs 67.3% before 8 weeks’ gestation; p = 0.003) with no other changes.

Conclusions/interpretation

A pragmatic community-based PPC programme was associated with clinically relevant improvements in pregnancy preparation in women with type 2 diabetes. To our knowledge, this is the first community-based PPC intervention to improve pregnancy preparation for women with type 2 diabetes.

Data availability

Further details of the data collection methodology, individual clinic data and the full audit reports for healthcare professionals and service users are available from https://​digital.​nhs.​uk/​data-and-information/​clinical-audits-and-registries/​our-clinical-audits-and-registries/​national-pregnancy-in-diabetes-audit.
Appendix
Available only for authorised users
Literature
1.
go back to reference Persson M, Norman M, Hanson U (2009) Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 32:2005–2009CrossRefPubMedPubMedCentral Persson M, Norman M, Hanson U (2009) Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 32:2005–2009CrossRefPubMedPubMedCentral
2.
go back to reference Macintosh MC, Fleming KM, Bailey JA et al (2006) Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333:177CrossRefPubMedPubMedCentral Macintosh MC, Fleming KM, Bailey JA et al (2006) Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333:177CrossRefPubMedPubMedCentral
3.
go back to reference Murphy HR, Bell R, Cartwright C et al (2017) Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Diabetologia 60:1668–1677CrossRefPubMedPubMedCentral Murphy HR, Bell R, Cartwright C et al (2017) Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Diabetologia 60:1668–1677CrossRefPubMedPubMedCentral
5.
go back to reference Murphy HR, Roland JM, Skinner TC et al (2010) Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care 33:2514–2520CrossRefPubMedPubMedCentral Murphy HR, Roland JM, Skinner TC et al (2010) Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care 33:2514–2520CrossRefPubMedPubMedCentral
6.
go back to reference Egan AM, Danyliv A, Carmody L, Kirwan B, Dunne FP (2016) A prepregnancy care program for women with diabetes: effective and cost saving. J Clin Endocrinol Metab 101:1807–1815CrossRefPubMed Egan AM, Danyliv A, Carmody L, Kirwan B, Dunne FP (2016) A prepregnancy care program for women with diabetes: effective and cost saving. J Clin Endocrinol Metab 101:1807–1815CrossRefPubMed
7.
go back to reference Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA (2010) Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth 10:63CrossRefPubMedPubMedCentral Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA (2010) Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth 10:63CrossRefPubMedPubMedCentral
8.
go back to reference Murphy HR, Steel SA, Roland JM et al (2011) Obstetric and perinatal outcomes in pregnancies complicated by type 1 and type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med 28:1060–1067CrossRefPubMedPubMedCentral Murphy HR, Steel SA, Roland JM et al (2011) Obstetric and perinatal outcomes in pregnancies complicated by type 1 and type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med 28:1060–1067CrossRefPubMedPubMedCentral
9.
go back to reference Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Thompson D, Berger H et al (2013) Diabetes and pregnancy. Can J Diabetes 37(Suppl 1):S168–S183 Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Thompson D, Berger H et al (2013) Diabetes and pregnancy. Can J Diabetes 37(Suppl 1):S168–S183
10.
go back to reference American Diabetes Association (2017) 13. Management of diabetes in pregnancy. Diabetes Care 40(Suppl 1):S114–S119CrossRef American Diabetes Association (2017) 13. Management of diabetes in pregnancy. Diabetes Care 40(Suppl 1):S114–S119CrossRef
11.
go back to reference Makda SI, Davies MJ, Wilmot E et al (2013) Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception. Diabet Med 30:457–463CrossRefPubMed Makda SI, Davies MJ, Wilmot E et al (2013) Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception. Diabet Med 30:457–463CrossRefPubMed
12.
go back to reference Klein J, Boyle JA, Kirkham R et al (2017) Preconception care for women with type 2 diabetes mellitus: a mixed-methods study of provider knowledge and practice. Diabetes Res Clin Pract 129:105–115CrossRefPubMed Klein J, Boyle JA, Kirkham R et al (2017) Preconception care for women with type 2 diabetes mellitus: a mixed-methods study of provider knowledge and practice. Diabetes Res Clin Pract 129:105–115CrossRefPubMed
13.
go back to reference Forde R, Patelarou EE, Forbes A (2016) The experiences of prepregnancy care for women with type 2 diabetes mellitus: a meta-synthesis. Int J Womens Health 8:691–703CrossRefPubMedPubMedCentral Forde R, Patelarou EE, Forbes A (2016) The experiences of prepregnancy care for women with type 2 diabetes mellitus: a meta-synthesis. Int J Womens Health 8:691–703CrossRefPubMedPubMedCentral
14.
go back to reference Murphy HR, Temple RC, Ball VE et al (2010) Personal experiences of women with diabetes who do not attend pre-pregnancy care. Diabet Med 27:92–100CrossRefPubMed Murphy HR, Temple RC, Ball VE et al (2010) Personal experiences of women with diabetes who do not attend pre-pregnancy care. Diabet Med 27:92–100CrossRefPubMed
15.
go back to reference Spence M, Alderdice FA, Harper R, McCance DR, Holmes VA (2010) An exploration of knowledge and attitudes related to pre-pregnancy care in women with diabetes. Diabet Med 27:1385–1391CrossRefPubMed Spence M, Alderdice FA, Harper R, McCance DR, Holmes VA (2010) An exploration of knowledge and attitudes related to pre-pregnancy care in women with diabetes. Diabet Med 27:1385–1391CrossRefPubMed
19.
go back to reference Feig DS, Donovan LE, Corcoy R et al (2017) Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 390:2347–2359CrossRefPubMedPubMedCentral Feig DS, Donovan LE, Corcoy R et al (2017) Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 390:2347–2359CrossRefPubMedPubMedCentral
Metadata
Title
Community-based pre-pregnancy care programme improves pregnancy preparation in women with pregestational diabetes
Authors
Jennifer M. Yamamoto
Deborah J. F. Hughes
Mark L. Evans
Vithian Karunakaran
John D. A. Clark
Nicholas J. Morrish
Gerry A. Rayman
Peter H. Winocour
Clare Hambling
Amanda W. Harries
Michael J. Sampson
Helen R. Murphy
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4613-3

Other articles of this Issue 7/2018

Diabetologia 7/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine